Type II Topoisomerases as Targets for Quinolone Antibacterials Turning Dr. Jekyll into Mr. Hyde

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|5|337-353

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.5, 2001-03, pp. : 337-353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospects for Developing New Antibacterials Targeting Bacterial Type IIA Topoisomerases

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 1, 2014-01 ,pp. : 130-151

Bentham Science Publishers

Access to resources Recommend Favorite

Hyaluronan: The Jekyll and Hyde Molecule

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 4, 2006-12 ,pp. : 257-260

Bentham Science Publishers

Access to resources Recommend Favorite

The ATP-Binding Site of Type II Topoisomerases as a Target for Antibacterial Drugs

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 283-303

Bentham Science Publishers

Access to resources Recommend Favorite

Dibenzo[1,6]naphthyridindiones as modified quinolone antibacterials

By Cecchetti V.   Fravolini A.   Sabatini S.   Tabarrini O.   Xin T.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 11, 1998-11 ,pp. : 899-903

Elsevier

Access to resources Recommend Favorite

DNA Topoisomerases as Targets for Antiprotozoal Therapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 6, 2003-09 ,pp. : 597-608

Bentham Science Publishers

Access to resources Recommend Favorite